| Primary |
| Nasopharyngitis |
46.2% |
| Product Used For Unknown Indication |
30.8% |
| Pyrexia |
15.4% |
| Headache |
7.7% |
|
| Emergency Care Examination Abnormal |
16.7% |
| Lip Swelling |
16.7% |
| Liver Transplant |
16.7% |
| Toxicologic Test Abnormal |
16.7% |
| Uveitis |
16.7% |
| Vomiting |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
55.4% |
| Drug Use For Unknown Indication |
15.4% |
| Pain |
3.6% |
| Migraine |
3.3% |
| Osteoarthritis |
3.0% |
| Asthma |
2.0% |
| Disseminated Tuberculosis |
2.0% |
| Drug Abuse |
2.0% |
| Intentional Self-injury |
1.6% |
| Pyrexia |
1.6% |
| Ill-defined Disorder |
1.3% |
| Suicide Attempt |
1.3% |
| Analgesic Therapy |
1.0% |
| Combined Immunodeficiency |
1.0% |
| Deep Vein Thrombosis |
1.0% |
| Epilepsy |
1.0% |
| Hypothyroidism |
1.0% |
| Intentional Drug Misuse |
1.0% |
| Prostate Cancer |
1.0% |
| Acute Myeloid Leukaemia |
0.7% |
|
| Product Quality Issue |
20.9% |
| Rash |
9.3% |
| Dyspnoea |
7.0% |
| Somnolence |
7.0% |
| Haematoma |
4.7% |
| Pulmonary Artery Stenosis |
4.7% |
| Pyrexia |
4.7% |
| Tachycardia |
4.7% |
| Tremor |
4.7% |
| Vomiting |
4.7% |
| Weight Decreased |
4.7% |
| Wrong Drug Administered |
4.7% |
| Alanine Aminotransferase Increased |
2.3% |
| Decreased Appetite |
2.3% |
| Drug Abuse |
2.3% |
| Drug Administration Error |
2.3% |
| Drug Intolerance |
2.3% |
| Drug Toxicity |
2.3% |
| Face Oedema |
2.3% |
| Influenza Like Illness |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Depression |
9.8% |
| Hypertension |
9.8% |
| Drug Use For Unknown Indication |
8.4% |
| Chronic Lymphocytic Leukaemia |
5.9% |
| Prophylaxis |
5.4% |
| Colorectal Cancer Metastatic |
3.9% |
| Osteoporosis |
3.2% |
| Neoplasm Malignant |
2.9% |
| Pain |
2.9% |
| Urinary Tract Infection |
2.9% |
| Epilepsy |
2.7% |
| Infection |
2.5% |
| Pancreatic Carcinoma Metastatic |
2.0% |
| Sarcoma Metastatic |
2.0% |
| Mucopolysaccharidosis Ii |
1.7% |
| Multiple Myeloma |
1.7% |
| Relapsing-remitting Multiple Sclerosis |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Anxiety |
1.5% |
|
| Vomiting |
10.1% |
| Thrombocytopenia |
7.2% |
| Renal Failure Acute |
5.8% |
| Tremor |
5.8% |
| Weight Decreased |
5.8% |
| Wheezing |
5.8% |
| Hyponatraemia |
5.0% |
| Toxicity To Various Agents |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Melaena |
4.3% |
| Myalgia |
4.3% |
| Pain In Extremity |
4.3% |
| Rash |
4.3% |
| Syncope |
4.3% |
| Tachycardia |
4.3% |
| Visual Impairment |
4.3% |
| Paraesthesia |
3.6% |
| Pyrexia |
3.6% |
| Transaminases Increased |
3.6% |
| Unresponsive To Stimuli |
3.6% |
|
